Dr. Gang Huang 黄钢
Chief Physician
Department of Bone and Soft Tissue Tumors, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of primary bone tumors, osteosarcoma neoadjuvant chemotherapy, limb-salvage therapy for malignant and aggressive bone tumors, benign bone tumors, soft tissue tumor resection and reconstruction, and diagnosis and treatment of bone metastases.
Dr. Huang is Chief Physician and Vice President at Hunan Cancer Hospital. Graduating from Central South University Xiangya School of Medicine in 1989, Dr. Huang completed advanced training in Shanghai, Tianjin, Paris, and Taiwan. Research focuses on bone and joint surgery, molecular mechanisms of bone metastases, and osteosarcoma chemotherapy sensitivity. Dr. Huang has published academic papers and received two provincial science and technology progress awards.
Name order: in Chinese the family name comes first (Huang Gang). Papers usually list the name as Gang Huang or Huang G.
Selected publications
20 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Bioeng Biotechnol, 2021 (senior author): Efficient and Consistent Orthotopic Osteosarcoma Model by Cell Sheet Transplantation in the Nude Mice for Drug Testing. PubMed 34631675
- Ann Surg Oncol, 2021 (senior author): Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy. PubMed 32929601
- Int J Surg, 2020 (senior author): Diagnostic accuracy of procalcitonin as an early predictor of infection after radical gastrectomy for gastric cancer: A prospective bicenter cohort study. PubMed 31978647
- Int J Biochem Cell Biol, 2019 (senior author): MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1. PubMed 30959202
- Tumour Biol, 2016 (senior author): Regulatory T cells in the immunotherapy of melanoma. PubMed 26515336
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion